{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:55:00Z","timestamp":1792598100091,"version":"4.5.0"},"reference-count":198,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,21]],"date-time":"2027-10-21T00:00:00Z","timestamp":1824076800000},"content-version":"am","delay-in-days":385,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023581","name":"National Science Foundation Graduate Research Fellowship Program","doi-asserted-by":"publisher","award":["DGE-2146755"],"award-info":[{"award-number":["DGE-2146755"]}],"id":[{"id":"10.13039\/100023581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Systems"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cels.2026.101716","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:37:34Z","timestamp":1791988654000},"page":"101716","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CAR T cells from code to clinic: Framing modeling approaches with current translational research goals"],"prefix":"10.1016","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3009-8072","authenticated-orcid":false,"given":"Lucas E.","family":"Sant\u2019Anna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohita","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janella C.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian I.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u00eblle N.","family":"Mayalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cels.2026.101716_bib1","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","article-title":"The Principles of Engineering Immune Cells to Treat Cancer","volume":"168","author":"Lim","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cels.2026.101716_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1188049","article-title":"From bench to bedside: the history and progress of CAR T cell therapy","volume":"14","author":"Mitra","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib3","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2114254","article-title":"Current updates on generations, approvals, and clinical trials of CAR T-cell therapy","volume":"18","author":"Asmamaw Dejenie","year":"2022","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cels.2026.101716_bib4","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.3390\/cancers15133476","article-title":"Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy","volume":"15","author":"Zheng","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.cels.2026.101716_bib5","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jcyt.2019.04.005","article-title":"The efficacy of anti-CD19 chimeric antigen receptor T cells for B-cell malignancies","volume":"21","author":"Cao","year":"2019","journal-title":"Cytotherapy"},{"key":"10.1016\/j.cels.2026.101716_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2378543","article-title":"Approved CAR-T therapies have reproducible efficacy and safety in clinical practice","volume":"20","author":"Goyco Vera","year":"2024","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.cels.2026.101716_bib149","article-title":"CAR-T cell therapy clinical trials: global progress, challenges, and future directions from ClinicalTrials.gov insights","volume":"16","author":"Cao","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib41","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cels.2026.101716_bib42","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.it.2015.06.004","article-title":"Engineering CAR-T cells: Design concepts","volume":"36","author":"Srivastava","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41417-025-00931-7","article-title":"Barriers and solutions for CAR-T therapy in solid tumors","volume":"32","author":"Tu","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.cels.2026.101716_bib8","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.15_suppl.e19068","article-title":"A mixed method analysis of toxicities of anti-CD19-CAR T cell therapy in hematological malignancies","volume":"37","author":"Jindal","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cels.2026.101716_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s13046-021-02148-6","article-title":"Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies","volume":"40","author":"Xiao","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cels.2026.101716_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.611366","article-title":"Characteristics and Risk Factors of Cytokine Release Syndrome in Chimeric Antigen Receptor T Cell Treatment","volume":"12","author":"Yan","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/1744666X.2019.1629904","article-title":"Tocilizumab for the treatment of chimeric antigen receptor T cell-induced cytokine release syndrome","volume":"15","author":"Kotch","year":"2019","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1144414","article-title":"CAR T-cell-associated neurotoxicity in central nervous system hematologic disease: Is it still a concern?","volume":"14","author":"Velasco","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cels.2026.101716_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-24010-1","article-title":"EEG-based grading of immune effector cell-associated neurotoxicity syndrome","volume":"12","author":"Jones","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cels.2026.101716_bib14","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor Antigen Escape from CAR T-cell Therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cels.2026.101716_bib34","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3343\/alm.2023.0388","article-title":"Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies","volume":"44","author":"Kim","year":"2024","journal-title":"Ann. Lab. Med."},{"key":"10.1016\/j.cels.2026.101716_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117252","article-title":"Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies","volume":"178","author":"Lin","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cels.2026.101716_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1546172","article-title":"Tandem CAR-T cell therapy: recent advances and current challenges","volume":"16","author":"G\u00f3mez-Melero","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-20893-2","article-title":"CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy","volume":"12","author":"Rodriguez-Garcia","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cels.2026.101716_bib18","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12935-024-03315-3","article-title":"Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors","volume":"24","author":"Chen","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cels.2026.101716_bib19","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.3390\/cells11223626","article-title":"Tumor Microenvironment Immunosuppression: A Roadblock to CAR T-Cell Advancement in Solid Tumors","volume":"11","author":"Johnson","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cels.2026.101716_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1080\/07388551.2021.1988509","article-title":"Addressing the obstacles of CAR T cell migration in solid tumors: wishing a heavy traffic","volume":"42","author":"Safarzadeh Kozani","year":"2022","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.cels.2026.101716_bib21","article-title":"Nanoengineered CAR-T Biohybrids for Solid Tumor Immunotherapy with Microenvironment Photothermal-Remodeling Strategy","volume":"17","author":"Chen","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.cels.2026.101716_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/s41586-025-09489-8","article-title":"In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma","volume":"646","author":"Knudsen","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cels.2026.101716_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adw9286","article-title":"Engineering CAR T cells to secrete VEGF-neutralizing scFvs enhances antitumor activity against solid tumors","volume":"18","author":"Gao","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cels.2026.101716_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.11","article-title":"Toxicity and management in CAR T-cell therapy","volume":"3","author":"Bonifant","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.cels.2026.101716_bib25","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/ard-2024-226142","article-title":"CD19-CAR T-cell therapy induces deep tissue depletion of B cells","volume":"84","author":"Tur","year":"2025","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cels.2026.101716_bib26","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2011-10-384388","article-title":"B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor\u2013transduced T cells","volume":"119","author":"Kochenderfer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.cels.2026.101716_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/mt.2010.24","article-title":"Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2","volume":"18","author":"Morgan","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.cels.2026.101716_bib28","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.cell.2016.09.011","article-title":"Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors","volume":"167","author":"Roybal","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.cels.2026.101716_bib29","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41586-023-05778-2","article-title":"Co-opting signalling molecules enables logic-gated control of CAR T cells","volume":"615","author":"Tousley","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cels.2026.101716_bib30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.abc1855","article-title":"T cell circuits that sense antigen density with an ultrasensitive threshold","volume":"371","author":"Hernandez-Lopez","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.abl5311","article-title":"Universal antigen encoding of T cell activation from high-dimensional cytokine dynamics","volume":"376","author":"Achar","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib32","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/j.cell.2025.03.017","article-title":"Engineering TCR-controlled fuzzy logic into CAR T cells enhances therapeutic specificity","volume":"188","author":"Kondo","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.cels.2026.101716_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103941","article-title":"Improving CAR-T immunotherapy: Overcoming the challenges of T cell exhaustion","volume":"77","author":"Gumber","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.cels.2026.101716_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.878209","article-title":"CAR-T Cell Performance: How to Improve Their Persistence?","volume":"13","author":"L\u00f3pez-Cantillo","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib36","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/s41551-021-00737-6","article-title":"T cells armed with C\u2013X-C chemokine receptor type 6 enhance adoptive cell therapy for pancreatic tumours","volume":"5","author":"Lesch","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cels.2026.101716_bib37","article-title":"Tissue-resident memory CAR T cells with stem-like characteristics display enhanced efficacy against solid and liquid tumors","volume":"4","author":"Jung","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cels.2026.101716_bib38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2019.09.006","article-title":"Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors","volume":"36","author":"Grosser","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cels.2026.101716_bib39","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1016\/j.apsb.2024.04.022","article-title":"Unlocking T cell exhaustion: Insights and implications for CAR-T cell therapy","volume":"14","author":"Xiong","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cels.2026.101716_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/1744666X.2024.2349738","article-title":"Overcoming the challenges of primary resistance and relapse after CAR-T cell therapy","volume":"20","author":"Dreyzin","year":"2024","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib43","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/psp4.12699","article-title":"Perspective on model-informed drug development","volume":"10","author":"Lesko","year":"2021","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.cels.2026.101716_bib44","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1158\/1078-0432.CCR-15-1433","article-title":"Making Better Chimeric Antigen Receptors for Adoptive T-cell Therapy","volume":"22","author":"Maus","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cels.2026.101716_bib45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib46","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib47","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/nm.3838","article-title":"4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors","volume":"21","author":"Long","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cels.2026.101716_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.mbs.2024.109141","article-title":"A stochastic framework for evaluating CAR T cell therapy efficacy and variability","volume":"368","author":"Hoang","year":"2024","journal-title":"Math. Biosci."},{"key":"10.1016\/j.cels.2026.101716_bib49","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13046-022-02327-z","article-title":"CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy","volume":"41","author":"Pan","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.cels.2026.101716_bib51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12943-024-02079-8","article-title":"Reshaping the tumor immune microenvironment to improve CAR-T cell-based cancer immunotherapy","volume":"23","author":"Xia","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.cels.2026.101716_bib52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41392-021-00812-z","article-title":"CAR-T: a potential gene carrier targeting solid tumor immune microenvironment","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cels.2026.101716_bib53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","article-title":"Navigating CAR-T cells through the solid-tumour microenvironment","volume":"20","author":"Hou","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cels.2026.101716_bib54","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.3390\/ijms25084170","article-title":"Car T Cells in Solid Tumors: Overcoming Obstacles","volume":"25","author":"Rojas-Quintero","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cels.2026.101716_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2025.105597","article-title":"Computational modelling of CAR T-cell therapy: from cellular kinetics to patient-level predictions","volume":"113","author":"Murias-Closas","year":"2025","journal-title":"EBiomedicine"},{"key":"10.1016\/j.cels.2026.101716_bib56","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2019.0734","article-title":"Mathematical deconvolution of CAR T-cell proliferation and exhaustion from real-time killing assay data","volume":"17","author":"Sahoo","year":"2020","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.cels.2026.101716_bib64","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.3390\/cancers13122941","article-title":"CARTmath\u2014A Mathematical Model of CAR-T Immunotherapy in Preclinical Studies of Hematological Cancers","volume":"13","author":"Barros","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cels.2026.101716_bib65","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3390\/cancers13040703","article-title":"Dual-Target CAR-Ts with On- and Off-Tumour Activity May Override Immune Suppression in Solid Cancers: A Mathematical Proof of Concept","volume":"13","author":"Le\u00f3n-Triana","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cels.2026.101716_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.cnsns.2020.105570","article-title":"CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models","volume":"94","author":"Le\u00f3n-Triana","year":"2021","journal-title":"Commun. Nonlinear Sci. Numer. Simul."},{"key":"10.1016\/j.cels.2026.101716_bib140","doi-asserted-by":"crossref","DOI":"10.34768\/amcs-2023-0027","article-title":"On the analysis of a mathematical model of CAR-T cell therapy for glioblastoma: Insights from a mathematical model","volume":"33","author":"Bodnar","year":"2023","journal-title":"Int. J. Appl. Math. Comput. Sci."},{"key":"10.1016\/j.cels.2026.101716_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/psp4.12388","article-title":"Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor\u2013T Cells","volume":"8","author":"Stein","year":"2019","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.cels.2026.101716_bib58","article-title":"The roles of T cell competition and stochastic extinction events in chimeric antigen receptor T cell therapy","volume":"288","author":"Kimmel","year":"2021","journal-title":"Proc. Biol. Sci."},{"key":"10.1016\/j.cels.2026.101716_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.849363","article-title":"Mapping CAR T-Cell Design Space Using Agent-Based Models","volume":"9","author":"Prybutok","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.cels.2026.101716_bib60","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1126\/science.abq0225","article-title":"Decoding CAR T cell phenotype using combinatorial signaling motif libraries and machine learning","volume":"378","author":"Daniels","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib61","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1126\/science.adv3813","article-title":"De novo design and structure of a peptide\u2013centric TCR mimic binding module","volume":"389","author":"Householder","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1126\/science.adv0422","article-title":"De novo-designed pMHC binders facilitate T cell\u2013mediated cytotoxicity toward cancer cells","volume":"389","author":"Johansen","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib63","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1126\/science.adv0185","article-title":"Design of high-specificity binders for peptide\u2013MHC-I complexes","volume":"389","author":"Liu","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1013117","article-title":"Spatiotemporal dynamics of tumor\u2013CAR T-cell interaction following local administration in solid cancers","volume":"21","author":"Owens","year":"2025","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib69","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/psp4.12598","article-title":"Bench-to-bedside translation of chimeric antigen receptor (CAR) T cells using a multiscale systems pharmacokinetic-pharmacodynamic model: A case study with anti-BCMA CAR-T","volume":"10","author":"Singh","year":"2021","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.cels.2026.101716_bib70","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2019.1688616","article-title":"Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model","volume":"12","author":"Singh","year":"2020","journal-title":"mAbs"},{"key":"10.1016\/j.cels.2026.101716_bib71","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/cts.12636","article-title":"Quantitative Systems Pharmacology Model of Chimeric Antigen Receptor T-Cell Therapy","volume":"12","author":"Hardiansyah","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.cels.2026.101716_bib72","article-title":"A Computational Model of Cytokine Release Syndrome during CAR T-Cell Therapy","volume":"5","author":"Zhang","year":"2022","journal-title":"Adv. Ther. (Weinh)"},{"key":"10.1016\/j.cels.2026.101716_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2025.116418","article-title":"Threshold dynamics of a stochastic tumor-immune model combined oncolytic virus and chimeric antigen receptor T cell therapies","volume":"197","author":"Zhou","year":"2025","journal-title":"Chaos Solitons Fractals"},{"key":"10.1016\/j.cels.2026.101716_bib74","first-page":"1","article-title":"Simulating the Evolution of Signaling Signatures During CART-Cell and Tumor Cell Interactions","volume":"2023","author":"Shah","year":"2023","journal-title":"Annu. Int. Conf. IEEE Eng. Med. Biol. Soc."},{"key":"10.1016\/j.cels.2026.101716_bib75","article-title":"Theoretical modeling techniques and their impact on tumor immunology","volume":"2010","author":"Woelke","year":"2010","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib76","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.bpj.2018.08.018","article-title":"Computational Model of Chimeric Antigen Receptors Explains Site-Specific Phosphorylation Kinetics","volume":"115","author":"Rohrs","year":"2018","journal-title":"Biophys. J."},{"key":"10.1016\/j.cels.2026.101716_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2019.110125","article-title":"Data-driven analysis of a mechanistic model of CAR T cell signaling predicts effects of cell-to-cell heterogeneity","volume":"489","author":"Cess","year":"2020","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib78","doi-asserted-by":"crossref","first-page":"3366","DOI":"10.1093\/bioinformatics\/btw469","article-title":"BioNetGen 2.2: advances in rule-based modeling","volume":"32","author":"Harris","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cels.2026.101716_bib79","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1084\/jem.20182375","article-title":"Single-cell imaging of CAR T cell activity in vivo reveals extensive functional and anatomical heterogeneity","volume":"216","author":"Cazaux","year":"2019","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cels.2026.101716_bib111","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1038\/s41591-022-01960-7","article-title":"Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy","volume":"28","author":"Good","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cels.2026.101716_bib112","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1182\/blood-2023-185088","article-title":"CART-AI-Radiomics: Survival and Neurotoxicity Prediction in B-Cell Lymphoma Patients Treated with CAR-T Cells through an Imaging Features-Based Model","volume":"142","author":"Ferrer Lores","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.cels.2026.101716_bib80","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1158\/2159-8290.CD-16-0040","article-title":"Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia","volume":"6","author":"Teachey","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cels.2026.101716_bib102","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1172\/JCI125423","article-title":"CD19 CAR T cell product and disease attributes predict leukemia remission durability","volume":"129","author":"Finney","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cels.2026.101716_bib105","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/s41551-026-01633-7","article-title":"Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer","volume":"10","author":"Chen","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.cels.2026.101716_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1692892","article-title":"Machine learning-based predictive model for high- grade cytokine release syndrome in chimeric antigen receptor T-cell therapy","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib81","article-title":"Mathematical models and computational approaches in CAR-T therapeutics","volume":"16","author":"Putignano","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.6","article-title":"Chimeric antigen receptor T-cell therapy for solid tumors","volume":"3","author":"Newick","year":"2016","journal-title":"Mol. Ther. Oncolytics"},{"key":"10.1016\/j.cels.2026.101716_bib83","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0984","article-title":"A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma","volume":"9","author":"O\u2019Rourke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cels.2026.101716_bib84","article-title":"Modeling interaction of Glioma cells and CAR T-cells considering multiple CAR T-cells bindings","volume":"9","author":"Li","year":"2023","journal-title":"ImmunoInformatics (Amst)"},{"key":"10.1016\/j.cels.2026.101716_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1115536","article-title":"Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variables","volume":"14","author":"Brummer","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib86","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41587-023-01687-x","article-title":"Deconvolution of clinical variance in CAR-T cell pharmacology and response","volume":"41","author":"Kirouac","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cels.2026.101716_bib87","series-title":"Philosophy of Statistics","first-page":"583","article-title":"AIC, BIC and Recent Advances in Model Selection","author":"Chakrabarti","year":"2011"},{"key":"10.1016\/j.cels.2026.101716_bib88","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1073\/pnas.1517384113","article-title":"Discovering governing equations from data by sparse identification of nonlinear dynamical systems","volume":"113","author":"Brunton","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2026.101716_bib89","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1371\/journal.pcbi.0030189","article-title":"Universally Sloppy Parameter Sensitivities in Systems Biology Models","volume":"3","author":"Gutenkunst","year":"2007","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib90","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jtbi.2012.12.025","article-title":"Quantifying T lymphocyte turnover","volume":"327","author":"De Boer","year":"2013","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib91","doi-asserted-by":"crossref","first-page":"6371","DOI":"10.3390\/ijms22126371","article-title":"A Mathematical Description of the Bone Marrow Dynamics during CAR T-Cell Therapy in B-Cell Childhood Acute Lymphoblastic Leukemia","volume":"22","author":"Mart\u00ednez-Rubio","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cels.2026.101716_bib92","doi-asserted-by":"crossref","DOI":"10.1063\/5.0260252","article-title":"A mathematical model of CAR-T cell therapy in combination with chemotherapy for malignant gliomas","volume":"35","author":"Sinelshchikov","year":"2025","journal-title":"Chaos"},{"key":"10.1016\/j.cels.2026.101716_bib93","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s11538-021-00869-5","article-title":"Modeling CAR T-Cell Therapy with Patient Preconditioning","volume":"83","author":"Owens","year":"2021","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib94","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-020-0073-9","article-title":"Radiopharmaceutical therapy in cancer: clinical advances and challenges","volume":"19","author":"Sgouros","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cels.2026.101716_bib95","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.035","article-title":"Current Status of Radiopharmaceutical Therapy","volume":"109","author":"St James","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.cels.2026.101716_bib96","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2307\/3579648","article-title":"The Linear-Quadratic Model and Most Other Common Radiobiological Models Result in Similar Predictions of Time-Dose Relationships","volume":"150","author":"Brenner","year":"1998","journal-title":"Radiat. Res."},{"key":"10.1016\/j.cels.2026.101716_bib97","doi-asserted-by":"crossref","first-page":"5171","DOI":"10.3390\/cancers13205171","article-title":"A Mathematical Modeling Approach for Targeted Radionuclide and Chimeric Antigen Receptor T Cell Combination Therapy","volume":"13","author":"Adhikarla","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cels.2026.101716_bib98","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cels.2026.101716_bib99","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005360","article-title":"Computational model of CAR T-cell immunotherapy dissects and predicts leukemia patient responses at remission, resistance, and relapse","volume":"10","author":"Liu","year":"2022","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cels.2026.101716_bib100","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.3390\/cancers14225576","article-title":"Modeling Patient-Specific CAR-T Cell Dynamics: Multiphasic Kinetics via Phenotypic Differentiation","volume":"14","author":"Paix\u00e3o","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.cels.2026.101716_bib101","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.3390\/cancers13112782","article-title":"Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model","volume":"13","author":"Mueller-Schoell","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.cels.2026.101716_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0282573","article-title":"Prediction of lymphoma response to CAR T cells by deep learning-based image analysis","volume":"18","author":"Tong","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.cels.2026.101716_bib104","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1182\/blood-2022-158543","article-title":"Prediction of Poor Outcome after Tisagenlecleucel in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL) Using Artificial Intelligence Analysis of Pre-Infusion PET\/CT","volume":"140","author":"Jak","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cels.2026.101716_bib106","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy\u2014assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cels.2026.101716_bib107","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cels.2026.101716_bib108","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cels.2026.101716_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1012908","article-title":"Mathematical modeling unveils the timeline of CAR-T cell therapy and macrophage-mediated cytokine release syndrome","volume":"21","author":"Santurio","year":"2025","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2026.1739021","article-title":"Immune effector cell-associated neurotoxicity syndrome: integrative mechanisms, predictive biomarkers, and translational pathways for prevention in CAR T-cell therapy","volume":"17","author":"Aziz","year":"2026","journal-title":"Front. Neurol."},{"key":"10.1016\/j.cels.2026.101716_bib114","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1073\/pnas.71.10.4135","article-title":"Kinetic Proofreading: A New Mechanism for Reducing Errors in Biosynthetic Processes Requiring High Specificity","volume":"71","author":"Hopfield","year":"1974","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2026.101716_bib115","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1073\/pnas.92.11.5042","article-title":"Kinetic proofreading in T-cell receptor signal transduction","volume":"92","author":"McKeithan","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2026.101716_bib116","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4049\/jimmunol.1700236","article-title":"Comparison of T Cell Activities Mediated by Human TCRs and CARs That Use the Same Recognition Domains","volume":"200","author":"Harris","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101023","article-title":"ERK Activation in CAR T Cells Is Amplified by CD28-Mediated Increase in CD3\u03b6 Phosphorylation","volume":"23","author":"Rohrs","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.cels.2026.101716_bib118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12964-022-00937-w","article-title":"Computational analysis of 4-1BB-induced NF\u03baB signaling suggests improvements to CAR cell design","volume":"20","author":"Tserunyan","year":"2022","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.cels.2026.101716_bib119","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11538-023-01232-6","article-title":"Information-Theoretic Analysis of a Model of CAR-4-1BB-Mediated NF\u03baB Activation","volume":"86","author":"Tserunyan","year":"2023","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-58600-8","article-title":"Integrative network modeling reveals mechanisms underlying T cell exhaustion","volume":"10","author":"Bolouri","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cels.2026.101716_bib121","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1158\/2326-6066.CIR-24-0089","article-title":"Transient EZH2 Suppression by Tazemetostat during In Vitro Expansion Maintains T-Cell Stemness and Improves Adoptive T-Cell Therapy","volume":"13","author":"Hou","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cels.2026.101716_bib122","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12859-026-06401-7","article-title":"Enhancing CAR-T cell activity prediction via fine-tuning protein language models with generated CAR sequences","volume":"27","author":"Yoshida","year":"2026","journal-title":"BMC Bioinform."},{"key":"10.1016\/j.cels.2026.101716_bib123","article-title":"Modeling chimeric antigen receptor response at the single-cell level with conditional optimal transport","volume":"17","author":"Driessen","year":"2026","journal-title":"Cell Syst."},{"key":"10.1016\/j.cels.2026.101716_bib124","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s11684-025-1130-x","article-title":"Tonic signaling in CAR-T therapy: the lever long enough to move the planet","volume":"19","author":"Huang","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.cels.2026.101716_bib125","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41422-023-00789-0","article-title":"Tuning charge density of chimeric antigen receptor optimizes tonic signaling and CAR-T cell fitness","volume":"33","author":"Chen","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.cels.2026.101716_bib126","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/s41422-024-00936-1","article-title":"CAR-Toner: an AI-driven approach for CAR tonic signaling prediction and optimization","volume":"34","author":"Qiu","year":"2024","journal-title":"Cell Res."},{"key":"10.1016\/j.cels.2026.101716_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apm.2023.08.029","article-title":"Mechanisms of resistance to CAR-T cell immunotherapy: Insights from a mathematical model","volume":"125","author":"Santurio","year":"2024","journal-title":"Appl. Math. Modell."},{"key":"10.1016\/j.cels.2026.101716_bib127","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.3390\/cells11193165","article-title":"Investigating Two Modes of Cancer-Associated Antigen Heterogeneity in an Agent-Based Model of Chimeric Antigen Receptor T-Cell Therapy","volume":"11","author":"Giorgadze","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cels.2026.101716_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fsysb.2022.923085","article-title":"A Mathematical Model for On-Target Off-Tumor Effect of CAR-T Cells on Gliomas","volume":"2","author":"Santurio","year":"2022","journal-title":"Front. Syst. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib129","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41540-024-00435-4","article-title":"Mathematical modeling insights into improving CAR T cell therapy for solid tumors with bystander effects","volume":"10","author":"Kara","year":"2024","journal-title":"NPJ Syst. Biol. Appl."},{"key":"10.1016\/j.cels.2026.101716_bib130","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202302171","article-title":"PASCAR: a multiscale framework to explore the design space of constitutive and inducible CAR T cells","volume":"6","author":"Rajakaruna","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.cels.2026.101716_bib131","doi-asserted-by":"crossref","first-page":"E888","DOI":"10.1073\/pnas.1300752110","article-title":"Phenotypic model for early T-cell activation displaying sensitivity, specificity, and antagonism","volume":"110","author":"Fran\u00e7ois","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2026.101716_bib132","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1365-3083.2002.01105.x","article-title":"Beyond Self and Nonself: Fuzzy Recognition of the Immune System","volume":"56","author":"Leng","year":"2002","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib133","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cels.2026.101716_bib134","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cels.2026.101716_bib135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1126\/science.add2187","article-title":"Robust deep learning\u2013based protein sequence design using ProteinMPNN","volume":"378","author":"Dauparas","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib136","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cels.2026.101716_bib137","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41591-022-01726-1","article-title":"PSMA-targeting TGF\u03b2-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial","volume":"28","author":"Narayan","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.cels.2026.101716_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.110427","article-title":"Geometric immunosuppression in CAR T-cell treatment: Insights from mathematical modeling","volume":"194","author":"Bordel-Vozmediano","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.cels.2026.101716_bib139","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2522634122","article-title":"Physiologically based pharmacokinetic model for CAR-T cell delivery and efficacy in solid tumors","volume":"122","author":"Hadjigeorgiou","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2026.101716_bib198","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"Jain","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib141","doi-asserted-by":"crossref","DOI":"10.5540\/tcam.2024.025.e01734","article-title":"A Mathematical Model to Describe the Melanoma Dynamics Under Effects of Macrophage Inhibition and CAR T-cell Therapy","volume":"25","author":"Rodrigues","year":"2024","journal-title":"Trends Comput. Appl. Math."},{"key":"10.1016\/j.cels.2026.101716_bib142","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0320","article-title":"A computational multiscale agent-based model for simulating spatio-temporal tumour immune response to PD1 and PDL1 inhibition","volume":"14","author":"Gong","year":"2017","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.cels.2026.101716_bib143","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40425-017-0313-7","article-title":"Mathematical modeling of tumor-associated macrophage interactions with the cancer microenvironment","volume":"6","author":"Mahlbacher","year":"2018","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.cels.2026.101716_bib144","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cpt.3703","article-title":"FDA Experience on CAR T Cell Pharmacokinetics\/Pharmacodynamics and Model-Based Assessments","volume":"118","author":"Tegenge","year":"2025","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.cels.2026.101716_bib145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The Protein Data Bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cels.2026.101716_bib146","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib147","doi-asserted-by":"crossref","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","article-title":"UniProt: the Universal Protein Knowledgebase in 2023","volume":"51","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cels.2026.101716_bib148","doi-asserted-by":"crossref","first-page":"D886","DOI":"10.1093\/nar\/gkae1142","article-title":"CZ CELLxGENE Discover: a single-cell data platform for scalable exploration, analysis and modeling of aggregated data","volume":"53","author":"Abdulla","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cels.2026.101716_bib150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/pr.117.013755","article-title":"Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration\u2013Approved Drugs","volume":"69","author":"Coussens","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.cels.2026.101716_bib151","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abm1463","article-title":"Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies","volume":"14","author":"Goodman","year":"2022","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cels.2026.101716_bib152","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/s41586-025-09507-9","article-title":"Systematic discovery of CRISPR-boosted CAR T cell immunotherapies","volume":"646","author":"Datlinger","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cels.2026.101716_bib153","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.cell.2022.02.015","article-title":"Spatial CRISPR genomics identifies regulators of the tumor microenvironment","volume":"185","author":"Dhainaut","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cels.2026.101716_bib154","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1016\/j.cell.2025.02.012","article-title":"Simultaneous CRISPR screening and spatial transcriptomics reveal intracellular, intercellular, and functional transcriptional circuits","volume":"188","author":"Binan","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.cels.2026.101716_bib155","article-title":"From Multi-Omics to Visualization and Beyond: Bridging Micro and Macro Insights in CAR-T Cell Therapy","volume":"12","author":"Gong","year":"2025","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.cels.2026.101716_bib156","doi-asserted-by":"crossref","first-page":"24275","DOI":"10.1073\/pnas.1903854116","article-title":"Long-term in vivo microscopy of CAR T cell dynamics during eradication of CNS lymphoma in mice","volume":"116","author":"Mulazzani","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cels.2026.101716_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115135","article-title":"Cellular and molecular imaging of CAR-T cell-based immunotherapy","volume":"203","author":"Liu","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.cels.2026.101716_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1011070","article-title":"Calibrating agent-based models to tumor images using representation learning","volume":"19","author":"Cess","year":"2023","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib159","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1126\/science.ade2574","article-title":"Evolutionary-scale prediction of atomic-level protein structure with a language model","volume":"379","author":"Lin","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib160","doi-asserted-by":"crossref","DOI":"10.1126\/science.ado9336","article-title":"Sequence modeling and design from molecular to genome scale with Evo","volume":"386","author":"Nguyen","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib161","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-023-06139-9","article-title":"Transfer learning enables predictions in network biology","volume":"618","author":"Theodoris","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cels.2026.101716_bib162","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/s41592-024-02305-7","article-title":"Large-scale foundation model on single-cell transcriptomics","volume":"21","author":"Hao","year":"2024","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cels.2026.101716_bib163","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-59926-5","article-title":"CellFM: a large-scale foundation model pre-trained on transcriptomics of 100 million human cells","volume":"16","author":"Zeng","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cels.2026.101716_bib164","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/s41592-025-02857-2","article-title":"Improved reconstruction of single-cell developmental potential with CytoTRACE 2","volume":"22","author":"Kang","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.cels.2026.101716_bib165","author":"Rohatgi"},{"key":"10.1016\/j.cels.2026.101716_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1008519","article-title":"Multi-scale modeling of macrophage-T cell interactions within the tumor microenvironment","volume":"16","author":"Cess","year":"2020","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib167","doi-asserted-by":"crossref","DOI":"10.1063\/5.0205996","article-title":"Integrating mechanism-based T cell phenotypes into a model of tumor-immune cell interactions","volume":"8","author":"Tangella","year":"2024","journal-title":"APL Bioeng."},{"key":"10.1016\/j.cels.2026.101716_bib168","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1016\/S2352-3026(25)00170-X","article-title":"Virtual twins for personalised CAR T-cell therapy in myeloma","volume":"12","author":"Reiche","year":"2025","journal-title":"Lancet Haematol."},{"key":"10.1016\/j.cels.2026.101716_bib169","article-title":"Interim results from the ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies","volume":"42","author":"Patel","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cels.2026.101716_bib170","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood-2021-151185","article-title":"Safety and Efficacy of FT596, a First-in-Class, Multi-Antigen Targeted, Off-the-Shelf, iPSC-Derived CD19 CAR NK Cell Therapy in Relapsed\/Refractory B-Cell Lymphoma","volume":"138","author":"Bachanova","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.cels.2026.101716_bib171","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40364-022-00364-6","article-title":"CAR-NK cells for cancer immunotherapy: from bench to bedside","volume":"10","author":"Zhang","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.cels.2026.101716_bib172","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/s41591-025-03495-z","article-title":"CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial","volume":"31","author":"Reiss","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.cels.2026.101716_bib173","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.cels.2026.101716_bib174","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s40164-025-00633-8","article-title":"The clinical landscape of CAR NK cells","volume":"14","author":"J\u00f8rgensen","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.cels.2026.101716_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtbi.2025.112263","article-title":"Mathematical model suggests current CAR-macrophage dosage is efficient to low pre-infusion tumour burden but refractory to high tumour burden","volume":"616","author":"Xu","year":"2026","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib176","article-title":"CAR T cells, CAR NK cells, and CAR macrophages exhibit distinct traits in glioma models but are similarly enhanced when combined with cytokines","volume":"6","author":"Look","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.cels.2026.101716_bib177","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1007468","article-title":"A mechanistic integrative computational model of macrophage polarization: Implications in human pathophysiology","volume":"15","author":"Zhao","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib178","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-48865-z","article-title":"Agent-based modeling and bifurcation analysis reveal mechanisms of macrophage polarization and phenotype pattern distribution","volume":"9","author":"Nickaeen","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cels.2026.101716_bib179","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0270779","article-title":"Agent-based vs. equation-based multi-scale modeling for macrophage polarization","volume":"19","author":"Minucci","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/j.cels.2026.101716_bib180","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.cels.2026.101716_bib181","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib182","article-title":"CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cels.2026.101716_bib183","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/s41392-024-02005-w","article-title":"Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization","volume":"9","author":"Chen","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cels.2026.101716_bib184","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1186\/s12885-025-14837-y","article-title":"A systematic review of the last two decades of NK cell-based clinical trials: state of the art of AML therapy","volume":"25","author":"Bakhtiyaridovvombaygi","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.cels.2026.101716_bib185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11538-023-01247-z","article-title":"Understanding the Interplay of CAR-NK Cells and Triple-Negative Breast Cancer: Insights from Computational Modeling","volume":"86","author":"Arabameri","year":"2024","journal-title":"Bull. Math. Biol."},{"key":"10.1016\/j.cels.2026.101716_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39689","article-title":"In silico assessment of CAR macrophages activity against SARS-CoV-2 infection","volume":"10","author":"Amoddeo","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.cels.2026.101716_bib187","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.3390\/cells11223692","article-title":"CAR-Macrophages and CAR-T Cells Synergistically Kill Tumor Cells In Vitro","volume":"11","author":"Liu","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cels.2026.101716_bib188","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1109\/MCS.2018.2810459","article-title":"Control Theory for Synthetic Biology: Recent Advances in System Characterization, Control Design, and Controller Implementation for Synthetic Biology","volume":"38","author":"Hsiao","year":"2018","journal-title":"IEEE Control Syst."},{"key":"10.1016\/j.cels.2026.101716_bib189","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006597","article-title":"PD-1\u2013 and CTLA-4\u2013Based Inhibitory Chimeric Antigen Receptors (iCARs) Divert Off-Target Immunotherapy Responses","volume":"5","author":"Fedorov","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cels.2026.101716_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.755639","article-title":"Inclusion of the Inducible Caspase 9 Suicide Gene in CAR Construct Increases Safety of CAR.CD19 T Cell Therapy in B-Cell Malignancies","volume":"12","author":"Guercio","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cels.2026.101716_bib191","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cell.2022.03.041","article-title":"Enhanced safety and efficacy of protease-regulated CAR-T cell receptors","volume":"185","author":"Labanieh","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cels.2026.101716_bib192","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba1786","article-title":"Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling","volume":"372","author":"Weber","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cels.2026.101716_bib193","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2014.07.033","article-title":"Paradoxical signaling by a secreted molecule leads to homeostasis of cell levels","volume":"158","author":"Hart","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cels.2026.101716_bib194","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.cell.2022.01.026","article-title":"Synthetic mammalian signaling circuits for robust cell population control","volume":"185","author":"Ma","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cels.2026.101716_bib195","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.arcontrol.2018.04.007","article-title":"Future systems and control research in synthetic biology","volume":"45","author":"Del Vecchio","year":"2018","journal-title":"Annu. Rev. Control"},{"key":"10.1016\/j.cels.2026.101716_bib196","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.3934\/dcdsb.2025080","article-title":"Optimal control of a mathematical model of CAR-T cell therapy for glioblastoma","volume":"30","author":"Bodzioch","year":"2025","journal-title":"DCDS-B"},{"key":"10.1016\/j.cels.2026.101716_bib197","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/cells13090726","article-title":"A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives","volume":"13","author":"Montoya","year":"2024","journal-title":"Cells"}],"container-title":["Cell Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405471226001985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405471226001985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:23:36Z","timestamp":1792596216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405471226001985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":198,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2405471226001985"],"URL":"https:\/\/doi.org\/10.1016\/j.cels.2026.101716","relation":{},"ISSN":["2405-4712"],"issn-type":[{"value":"2405-4712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAR T cells from code to clinic: Framing modeling approaches with current translational research goals","name":"articletitle","label":"Article Title"},{"value":"Cell Systems","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cels.2026.101716","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101716"}}